12:00 AM
 | 
Sep 13, 2004
 |  BC Week In Review  |  Company News  |  Management Tracks

Santhera Pharmaceuticals AG board of directors update

Santhera Pharmaceuticals AG, Liestal, Switzerland
Business: Musculoskeletal, Metabolic, Functional genomics
Appointed: Mark Clement, CEO of Merlin...

Read the full 56 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >